ASCELLA THERAPEUTICS
Live / Registered — Registered (as of 14 Feb 2023)
What this means for you
Registered since 14 Feb 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88153394
- Registration number
- 6980529
- Mark type
- Stylized text
- Filed
- 12 Oct 2018
- Published for opposition
- 19 Mar 2019
- Registered
- 14 Feb 2023
- Attorney of record
- Julia Spoor Gard
Goods and services
- Class 042 — Scientific and technological services: pharmaceutical research and development; pharmaceutical products development
Owner
- Ascella Therapeutics, Inc., South San Francisco, CA, US
- Ascella Therapeutics, Inc., South San Francisco, CA, US
- Ascella Therapeutics, Inc., San Francisco, CA, US
Prosecution history
- 14 Feb 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Feb 2023 — REGISTERED-PRINCIPAL REGISTER
- 07 Jan 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Jan 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Nov 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Nov 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Nov 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Jul 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Jul 2022 — NON-FINAL ACTION E-MAILED
- 19 Jul 2022 — SU - NON-FINAL ACTION - WRITTEN
- 17 Jul 2022 — ASSIGNED TO EXAMINER
- 20 May 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 12 May 2022 — USE AMENDMENT FILED
- 12 May 2022 — TEAS STATEMENT OF USE RECEIVED
- 15 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED